ASX-Dividend-Report-Banner

Amorepacific Announces Positive Research Results of Fermented Ginseng in Skin Lymphatic Activation

February 07, 2024 01:00 AM AEDT | By Cision
Follow us on Google News: https://kalkinemedia.com/resources/assets/public/images/google-news.webp
 Amorepacific Announces Positive Research Results of Fermented Ginseng in Skin Lymphatic Activation
Image source: Kalkine Media

Reveals potential improvement in lymphatic activation and skin health through fermented ginseng ingredients

SEOUL, South Korea, Feb. 6, 2024 /PRNewswire/ -- Amorepacific, in collaboration with the School of Mechanical Engineering at Korea University, has unveiled groundbreaking research demonstrating the impact of lymphatic activation on skin health and the potential skin lymphatic improvement through fermented ginseng ingredients. This research, introducing new possibilities for skin aging and homeostasis maintenance using Lab-on-a-chip technology, was published in 'NPG Asia Materials,' an international journal by the scientific journal Nature. (Paper Title: The advanced 3D lymphatic system for assaying the human cutaneous lymphangiogenesis in the microfluidic platform)

With the Skin-Lymph-on-a-chip system, Amorepacific found that Lymphanax™, made from ginseng naturally fermented for 500 hours, can strengthen the skin barrier and aid internal skin circulation.
With the Skin-Lymph-on-a-chip system, Amorepacific found that Lymphanax™, made from ginseng naturally fermented for 500 hours, can strengthen the skin barrier and aid internal skin circulation.

The lymphatic system, a crucial organ for maintaining homeostasis and activating the immune system through circulation and waste removal, plays a significant role in skin health. Disruption in lymphatic circulation within the skin can lead to problems and accelerated aging. However, directly observing changes in living tissue's most profound lymphatic systems has been challenging. The R&I Center at Amorepacific and Professor Chung Seok's laboratory at the School of Mechanical Engineering, Korea University, have been conducting extensive research to elucidate the interdependent relationship between lymph circulation and skin.

The joint research team utilized state-of-the-art human skin structure replication technology and Lab-on-a-chip systems, a type of organoid technology enabling the observation of networks between various cells. In this research, they cultivated human-derived skin cells and 3D lymphatic forming cells under optimal conditions to create a Skin-Lymph-on-a-chip. This enabled the replication of networks between human skin and lymphatic vessels, visually observing the impact of substances applied to the skin on lymphatic formation and activity.

This system, which mimics the network between human skin and lymphatics, can observe the impact of substances applied to the skin on lymphatic formation and check molecular biological changes. Amorepacific's Lymphanax™, made from ginseng naturally fermented for 500 hours and rich in the lymph-activating component Gypenoside XVII, has been proven to strengthen the skin barrier and aid internal skin circulation, as observed in the Skin-Lymph-on-a-chip system. The joint research team concluded that Lymphanax™ aids in forming healthy lymphatic vessels within the skin and strengthens the skin barrier through additional analysis, including AI algorithms.

Lymphatic vessels were significantly activated on the Skin-Lymph-on-a-chip treated with Lymphanax™.
Lymphatic vessels were significantly activated on the Skin-Lymph-on-a-chip treated with Lymphanax™.

Suh Byung-fhy, CTO of Amorepacific's R&I Center, stated, "This research has, for the first time, clarified the correlation between human skin and lymphatic vessels, and particularly, it is meaningful as it confirms the efficacy of ginseng ingredients, a subject of long-term research by Amorepacific. Based on the achievements in the skin biofield from this research, Amorepacific will continue to strive to provide innovative solutions for the health and beauty of customers worldwide."

Meanwhile, Lymphanax™, whose efficacy was confirmed in this study, is currently being used as a critical ingredient in the Sulwhasoo brand.

https://www.nature.com/articles/s41427-023-00527-3


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles

Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.